From the ∗Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine
†Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
‡Department of Radiology, Children’s Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Received for publication September 11, 2022; revision accepted September 14, 2022.
Conflicts of interest and sources of funding: The authors declare that they have no conflicts of interest. This study was supported by the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (grant number: CF 2021-I2M-1-2-2022564).
Correspondence to: Fang Li, MD, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, No. 1 Shuaifuyuan, Wangfujing St, Dongcheng District, Beijing 100730, China. E-mail: [email protected]; Anli Tong, MD, PhD, Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. E-mail: [email protected]; and Hongli Jing, MD, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, No. 1 Shuaifuyuan, Wangfujing St, Dongcheng District, Beijing 100730, China. E-mail: [email protected].
